Damián Alvarez-Paggi
Damián Alvarez-Paggi is a prominent Argentine researcher specializing in nanobioengineering. He is known for his work at the Conicet and as the founder and CEO of Eureka Nanobioengineering. Recently, he was in the news for being the first author of a significant study published in The Lancet, which identified multiple phenotypes of bronchopulmonary dysplasia in premature infants, aiming to improve diagnostic accuracy and treatment strategies.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Argentina:
Damián Alvarez-Paggi is the first author of the work and specializes in nanobioengineering.
9